Stockreport

Aura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights [Yahoo! Finance]

Aura Biosciences, Inc.  (AURA) 
PDF Data Expected Mid-2024 from Ongoing Phase 1 Trial in Bladder Cancer (Non-Muscle Invasive Bladder Cancer and Muscle Invasive Bladder Cancer) Strong Cash Position into [Read more]